Indoline anti-cancer agents
US8334311B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2011 |
| Grant date | Dec 18, 2012 |
| Priority date | — |
| Expiry date | Jul 25, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Indoline compounds having anti-mitotic activity, useful for the treatment of cancer and other proliferative disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.